LEC 6 -THE LYMPHORETICULAR SYSTEM 2-3
LEC 6 -THE LYMPHORETICULAR SYSTEM 2-3
LEC 6 -THE LYMPHORETICULAR SYSTEM 2-3
DR J E OKWARA
• The lymphoreticular system consists of the tissues of
• The lymphoid system
• and the mononuclear phagocyte system (reticuloendothelial system)
• The lymphoid system consists of
• The spleen,
• Lymphnodes,
• Lymphatic vessels,
• Thymus,
• Bone marrow
• The lymphoid tissues associated with the GIT-eg tonsils, Payer
patches
Primary and Secondary lymphoid organs
• The bone marrow and the thymus are the primary
lymphoid organs. Site where T and B cells become
immunocompetent:able to recognize and respond to
antigens
• While the spleen and the lymph nodes are the major
secondary lymphoid organs. Immunocompetent cells
populate these tissues
Functions of the LRS
• The functions of these systems include
• Collection and transport of interstitial fluid-Fluid balance
• Fluid continually filters from the blood capillaries into
the tissue spaces
• • Blood capillaries reabsorb 85%
• • 15% (2 to 4 L/day) of the water and about half of the
plasma proteins enter the lymphatic system and then are
returned to the blood
Functions of the LRS
• Transport of fats throughout the body
• Generalized and
• Localized:
CLASSIFICATION OF LYMPADENOPATHY
• Localized lymphadenopathy:Localized
lymphadenopathy: due to localized spot of asault
• Occurs in contiguous groupings of lymph nodes.
• In discrete anatomical regions, lymph nodes are
distributed, and their enlargement represents their
location's lymphatic drainage.
• 75% of all lymphadenopathies are localized
• Over 50% seen in the region of the head and neck.
• Generalized lymphadenopathy:
• Involves lymphadenopathy in 2 or more non-contiguous
sites
• Due to generalized infection all over the body e.g.
influenza : due to systemic infection.
• In some cases, it may persist for prolonged periods
possibly without an apparent cause- Persistent
generalized lymphadenopathy (PGL)
•
• Malignant or Benign lymphadenopathy
• Malignant types which mainly refer to lymphomas
• Metastatic or non- metastatic.